Table 2 Distribution of metabolic syndrome components, cardiovascular disease risk factors and coronary heart disease in the study population.
| Variable | Women | Men | All patients | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RA (n = 147; %) | Controls (n = 294; %) | p Value* | RA (n = 53; %) | Controls (n = 106; %) | p Value | RA (n = 200; %) | Controls (n = 400; %) | p Value | |
| Fasting glucose ⩾110 mg/dl | 45 (30.6) | 94 (32) | 0.8 | 14 (26.4) | 38 (35.8) | 0.2 | 59 (29.5) | 132 (33) | 0.4 |
| Triglycerides ⩾150 mg/dl | 44 (29.9) | 80 (27.2) | 0.5 | 19 (35.8) | 32 (30.2) | 0.5 | 63 (31.5) | 112 (28) | 0.4 |
| HDL‐C <50 mg/dl (♀)/40 mg/dl (♂) | 47 (32) | 74 (25.2) | 0.1 | 17 (32.1) | 17 (16) | 0.02 | 64 (32) | 91 (22.8) | 0.02 |
| Waist circumference>88 cm (♀)/>102 cm (♂) | 110 (74.8) | 267 (90.8) | 0.001 | 32 (60.4) | 65 (61.3) | 0.9 | 142 (71) | 332 (83) | 0.001 |
| Arterial blood pressure ⩾130/85 mm Hg | 97 (66) | 219 (74.5) | 0.06 | 35 (66) | 91 (85.8) | 0.004 | 132 (66) | 310 (77.5) | 0.003 |
| Total cholesterol ⩾200 mg/dl | 95 (64.6) | 227 (77.2) | 0.005 | 31 (58.5) | 75 (70.8) | 0.1 | 126 (63) | 302 (75.5) | 0.001 |
| LDL‐C ⩾130 mg/dl | 82 (55.8) | 194 (66.2) | 0.03 | 25 (47.2) | 61 (57.5) | 0.2 | 107 (53.5) | 255 (63.9) | 0.01 |
| Family history of CHD | 32 (21.8) | 84 (28.6) | 0.1 | 9 (17.0) | 36 (34) | 0.04 | 41 (20.5) | 120 (30) | 0.02 |
| Current smoking | 16 (10.9) | 25 (8.5) | 0.4 | 14 (26.4) | 30 (28.3) | 0.9 | 30 (15) | 55 (13.8) | 0.6 |
| CHD | 10 (6.8) | 10 (3.4) | 0.1 | 13 (24.5) | 19 (17.9) | 0.3 | 23 (11.5) | 29 (7.3) | 0.09 |
CHD, coronary heart disease; CVD, cardiovascular diseases; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; MetS, metabolic syndrome; RA, rheumatoid arthritis.
Significant (p<0.05) differences are highlighted in bold.
*Difference between patients with rheumatoid arthritis and controls.